Cairdac raises 17 million for its pacemaker

Cairdac raises 17 million for its pacemaker

Cairdac develops the first selsf-sutainable leadless pacemaker. The Paris-based medtech company has announced that it has finalized its Serie A at €17 million, planning to start clinical studies mid-2023 in Europe.